Cancer immunotherapy at the crossroads : how tumors evade immunity and what can be done /
| Other Authors: | , |
|---|---|
| Format: | Book |
| Language: | English |
| Published: |
Totowa, N.J. :
Humana Press,
[2004]
|
| Series: | Current clinical oncology (Totowa, N.J.)
|
| Subjects: |
Table of Contents:
- HLA class I antigen-processing machinery and HLA class I antigen-derived peptide-complex defects in tumor-cell escape
- Immune defects in T cells from cancer patients : parallels in infectious diseases
- Malfunction of the dendritic cell system in cancer
- CD4+T-cell-mediated immunity to cancer
- Immunological ignorance in cancer
- The role of receptor-mediated apoptosis in T-cell dysfunction
- Alterations in T-cell signaling pathways and increased sensitivity to apoptosis
- The role of tumor gangliosides in the immune dysfunction of cancer
- Interleukin-10-induced immune suppression in cancer
- Accentuating tumor immunity through costimulation : a detailed analysis of OX40 engagement and CTLA-4 blockade
- Optimizing T-cell adoptive immunotherapy to overcome tumor evasion
- Tumor resistance to apoptosis : mechanisms of evasion and implications for radiation and chemotherapeutic strategies
- The development and reversal of T-cell tolerance in cancer patients receiving peptide-based vaccines
- Altered signaling in T lymphocytes of patients with cancer : a biomarker of prognosis?
- Allogenic hematopoietic blood-cell transplantation as immunotherapy for metastatic renal cell carcinoma
- Immune defects in patients suffering from non-Hodgkin's lymphoma
- Immune dysfunction in classical Hodgkin's lymphoma
- Lung cancer and immune dysfunction
- Primary malignant brain tumors : immune defects and immune evasion